Affordable Access

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response.

Authors
Type
Published Article
Journal
Breast (Edinburgh, Scotland)
Publication Date
Volume
16
Issue
1
Pages
86–93
Identifiers
PMID: 17010609
Source
Medline

Abstract

Statistics

Seen <100 times